A prevention strategy developed by BC researchers reduces the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent, according to a new UBC study published today in JAMA Network Open.
A new study led by BC Cancer researchers shows that classic Hodgkin lymphoma (CHL) is not one disease, but several biologically distinct subtypes.
On behalf of Nursing Research, Clinical Research Department, BC Cancer Research Institute (formerly BC Cancer Nursing and Allied Health Research and Knowledge Translation) and Professional Practice.
On behalf of Dr. François Bénard, Senior Executive Director, Research, BC Cancer
We are pleased to announce the BC Cancer 2026 Summer Research Studentship competition.
Clinical nurse specialists (CNSs) are graduate-prepared nurses with expertise in both clinical care and systems improvement. They lead practice change, support interdisciplinary teams, and bring a nursing lens to health service planning and evaluation.
Two BC Cancer researchers are recipients of 2025 Operating Grants from the Cancer Research Society.
Dr. Florian Kuchenbauer received a grant for the project, “Targeting APOBEC3B-induced replication stress in multiple myeloma with TP53 abnormalities.”
Dr. Peter Stirling received a grant for the project, “Inhibiting DNA2 nuclease for selective killing of ALT positive cancers.”
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.